Literature DB >> 19929569

Instrument measurement of lingual force variability reflects tardive tongue dyskinesia.

J P Koning1, D E Tenback, R S Kahn, L J Van Schelven, P N Van Harten.   

Abstract

Tardive tongue dyskinesia is often under-diagnosed or misdiagnosed. Instrument measurement of lingual force variability may be a valid and reliable method for assessing tardive tongue dyskinesia. Instrument measurement of lingual force variability was compared to the clinical level of tardive tongue dyskinesia and total body dyskinesia as measured by the Abnormal Involuntary Movement Scale (AIMS) in 35 subjects: 23 patients with a psychiatric disorder using antipsychotics, of which 11 were with and 12 were without tardive tongue dyskinesia, and 12 age- and gender-matched healthy controls. Lingual force variability correlated with tardive tongue dyskinesia (Spearman r = 0.56; p < 0.01) and with total dyskinesia (r = 0.47; p = 0.02); there was no association with age, antipsychotic dose, or psychiatric diagnosis. Instrument test-retest reliability corresponded with an ICC of 0.85 p < 0.0001. Instrument measurement of lingual force variability is a valid and reliable method for assessing tardive tongue dyskinesia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19929569     DOI: 10.3109/03091900903402105

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  8 in total

Review 1.  Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.

Authors:  Katharina Stegmayer; Sebastian Walther; Peter van Harten
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

2.  The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.

Authors:  Moogeh Baharnoori; Cali Bartholomeusz; Aurelie A Boucher; Lisa Buchy; Christopher Chaddock; Bonga Chiliza; Melanie Föcking; Alex Fornito; Juan A Gallego; Hiroaki Hori; Gisele Huf; Gul A Jabbar; Shi Hyun Kang; Yousri El Kissi; Jessica Merchán-Naranjo; Gemma Modinos; Nashaat A M Abdel-Fadeel; Anna-Karin Neubeck; Hsiao Piau Ng; Gabriela Novak; Olasunmbo O Owolabi; Diana P Prata; Naren P Rao; Igor Riecansky; Darryl C Smith; Renan P Souza; Renate Thienel; Hanan D Trotman; Hiroyuki Uchida; Kristen A Woodberry; Anne O'Shea; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2010-10-08       Impact factor: 4.939

Review 3.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

4.  Motor Disturbance in ASD: A Pilot Study Showing Hypokinetic Behavior?

Authors:  M A L Mostert-Kerckhoffs; A E Willems; D E Tenback; J P Koning; P Van Harten; W G Staal
Journal:  J Autism Dev Disord       Date:  2020-02

5.  Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.

Authors:  P Roberto Bakker; Egbert Bakker; Najaf Amin; Cornelia M van Duijn; Jim van Os; Peter N van Harten
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 6.  Movement disorders and psychosis, a complex marriage.

Authors:  Peter N van Harten; P Roberto Bakker; Charlotte L Mentzel; Marina A Tijssen; Diederik E Tenback
Journal:  Front Psychiatry       Date:  2015-01-09       Impact factor: 4.157

7.  A Study on Drug-Induced Tardive Dyskinesia: Orofacial Musculature Involvement and Patient's Awareness.

Authors:  Arunachalam M Anusa; Rooban Thavarajah; Dinesh Nayak; Elizabeth Joshua; Umadevi Krishnamohan Rao; Kannan Ranganathan
Journal:  J Orofac Sci       Date:  2019-01-02

8.  Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study.

Authors:  P Roberto Bakker; Asmar F Y Al Hadithy; Najaf Amin; Cornelia M van Duijn; Jim van Os; Peter N van Harten
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.